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Members of the NR3B group of the nuclear receptor superfamily, known as the estrogen-related receptors
(ERRs), were the first orphan receptors to be identified two decades ago. Despite the fact that a natural ligand
has yet to be associated with the ERRs, considerable knowledge about their mode of action and biological
functions has emerged through extensive biochemical, genetic and functional genomics studies.This review
describes our current understanding of how the ERRs work as transcription factors and as such, how they
control diverse developmental and physiological programs.
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Introduction
The nuclear receptor (NR) superfamily was originally
defined as a group of structurally-related transcription
factors controlling gene expression in response to binding
to small lipophilic ligands best represented by the steroid
and thyroid hormones, as well as vitamin D and the active
derivatives of vitamin A [Evans, 1988]. However, it was
soon realized that the number of nuclear receptors
exceeded the number of known, classic lipophilic
hormones, and receptors that could not be matched with
a natural ligand were labeled as orphan nuclear receptors
[Giguere, 1999; Giguere et al., 1988].The emerging
challenge was to perform “reverse endocrinology”, starting
with a gene encoding a putative receptor and ending up
with a corresponding natural ligand and/or the recognition
of the developmental and physiological processes
modulated by these receptor-like proteins [Kliewer et al.,
1999]. Here, we will review the current knowledge on the
NR3B subgroup of nuclear receptors, commonly known
as estrogen-related receptors (ERRs), the first orphan




The NR3B subgroup includes three nuclear receptors
referred to as ERRα (NR3B1, ERR1, ESRRA), ERRβ
(NR3B2, ERR2, ESRRB) and ERRγ (NR3B3, ERR3,
ESRRG), respectively. Members of the NR3B subgroup
belong to the larger NR3 class of nuclear receptors that
includes the classic steroid hormone receptors for
estrogens, androgens, progesterone, aldosterone and
cortisol.The first member of the subgroup (ERRα) was
originally identified owing to the significant nucleotide and
primary amino acid sequence similarities that it shared
with the estrogen receptor α (NR2B1) gene and protein,
while ERRβ was identified using the ERRα cDNA as a
probe [Giguere et al., 1988]. Ironically, while ERRα was
the first orphan nuclear receptor identified, ERRγ was the
final addition to the superfamily [Eudy et al., 1998; Heard
et al., 2000; Hong et al., 1999]. Although ERR homologs
also exist in invertebrates such as Drosophila [Sullivan
and Thummel, 2003] and amphioxus (Branchiostoma
floridae) [Bardet et al., 2005], suggesting an ancient origin
for the ERRs, it is not yet possible to identify the ancestral
member of the NR3 group [Bardet et al., 2006].The
genomic organization of the three ERR loci also shares
a structural characteristic unique among receptor isoforms
within a subgroup of the superfamily.The exon encoding
the amino terminal domain of the receptor also encodes
the first zinc finger of the DNA binding domain, a genetic
link between the two domains that could explain the
unusual level of amino acid sequence identity present in
the amino terminal domains of the three ERR isoforms.
A single polypeptide of 423 amino acid residues encodes
human ERRα, while several splice variants of ERRβ and
γ have been identified in human (Figure 1A).The ERRβ2
variant contains an extended carboxy-terminal domain
[Chen et al., 1999], ERRβ2Δ10 lacks exon 10 and
encodes a different carboxy-terminal region [Zhou et al.,
2006], the ERRγ2 splice variant possesses an additional
23 amino acids within its amino-terminal domain [Heard
et al., 2000; Susens et al., 2000], while a new ERRγ splice
variant lacking 39 amino acid residues of the second zinc
finger of the DNA-binding domain has been found to be
expressed in adipocytes and the prostate [Kojo et al.,
2006].The existence and relative abundance of most of
these isoforms need to be confirmed by endogenous
protein detection assays, while further studies are
required to elucidate their putative physiological roles.
Expression of the ERR isoforms
In general, the ERRs display a similar tissue distribution
in both mice and humans.The ERR isoforms are
ubiquitously expressed. However, ERRα is generally
more abundantly expressed than ERRγ, which in turn is
more abundant than ERRβ.The three isoforms are
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energy demand, such as the heart and kidneys. ERRα
is also expressed at high levels in the intestine, brown
adipose tissue and skeletal muscles, while ERRγ mRNA
can be found in abundance in the brain stem and the
spinal cord. ERRβ can be found at relatively high levels
in a subset of extra-embryonic ectoderm in the developing
placenta and undifferentiated trophoblast stem cell lines,
as well as in the adult eyes, inner ear, heart and kidneys
[Bookout et al., 2006; Chen and Nathans, 2007; Giguere
et al., 1988; Luo et al., 1997; Pettersson et al., 1996;
Tremblay et al., 2001b].The graphical views of the
tissue-specific mRNA expression patterns for the three
mouse ERR isoforms are available at [Bookout et al.,
2005].
Figure 1.  Schematic representation of ERR structures and DNA
binding mode. A) Schematic structure of the various ERR isoforms.
Like most nuclear receptors, the ERRs possess three core domains, a
regulatory amino-terminal domain (NTD), a DNA binding domain (DBD)
and a ligand binding domain (LBD), in which the activation function 2
(AF-2, white box) is embedded at its carboxy terminal end.The AF-2 is
required for ERR interaction with the coactivator PGC-1 and corepressor
RIP140. B) Consensus ERR response element, as defined by motif-finding
algorithms of ERR target gene promoters (Dufour et al., 2007). C) ERRs
can bind to the ERRE as monomers, homodimers and heterodimers.
Interestingly, it was shown that the expression of all three
ERR isoforms displays distinct diurnal rhythmicity in
tissues such as the liver, white adipose, skeletal muscle,
uterus and bone [Horard et al., 2004;Yang et al., 2006],
suggesting that the ERRs may serve as a molecular link
between the circadian oscillator and energy metabolism
(see below). In addition, physiological stress signals such
as exposure to cold, exercise or fasting also induce ERRα
expression in brown fat, skeletal muscles and liver,
respectively [Cartoni et al., 2005; Ichida et al., 2002;
Schreiber et al., 2003]. It has also been shown that ERRα
expression in bone marrow-derived macrophages is
activated by lipopolysaccharide, interferon γ (IFN-γ) and
interleukin 4 [Barish et al., 2005; Sonoda et al., 2007]. In
addition, a 2-fold increase of ERRα mRNA expression
has been demonstrated during differentiation of human
bone marrow-derived mesodermal progenitor cells into
osteoblasts [Qi et al., 2003].
Little is known about how the expression of the three ERR
genes is controlled.The main regulator of ERRα
expression has been shown to be the ERRs themselves
[Laganiere et al., 2004; Liu et al., 2005; Mootha et al.,
2004].The ESRRA promoter contains a polymorphic 23
base pair sequence (ESRRA23) that is present in 1-4
copies in human. Each ESRRA23 element contains one
perfect ERRE, as well as an additional nuclear receptor
half-site.Transient transfection experiments have
demonstrated that induction of the ESRRA promoter by
PGC-1α is dependent on the presence of the ESRRA23
element, and that the strength of the activation correlates
with its dosage [Laganiere et al., 2004].
Transcriptional activity of the ERRs
Interactions with coregulatory proteins
The three ERRs are constitutively active transcription
factors.Their transactivation properties are independent
of any exogenously added natural ligand and their relative
potency as transcriptional activators varies in cell context-
and promoter-dependent manners.The three ERR
isoforms bind to a number of coregulator proteins, which
they also share with other NRs.Their transcriptional
activity is increased by members of the steroid receptor
coactivator (SRC) family (SRC-1, TIF-2/SRC-2,
AIB1/ACTR/SRC-3) [Hong et al., 1999; Xie et al., 1999;
Zhang and Teng, 2000], the peroxisome
proliferator-activated receptor γ coactivator-1 (PGC-1) α
and β [Huss et al., 2002; Kamei et al., 2003; Laganiere
et al., 2004; Schreiber et al., 2003; Sonoda et al., 2007],
as well as the proline-rich nuclear receptor coregulatory
protein (PNRC), PNRC2 and transducin-like enhancer of
split 1 [Hentschke and Borgmeyer, 2003; Zhou and Chen,
2001; Zhou et al., 2000].The transcriptional activity of
the ERRs is also modulated by the nuclear receptor
corepressor RIP140/Nrip1 [Augereau et al., 2006; Castet
et al., 2006; Debevec et al., 2007; Sanyal et al., 2004].
The ERRs can interact with the orphan nuclear receptor
small heterodimer partner (SHP; NR0B2), which
represses their transcriptional activity [Sanyal et al., 2002].
SHP lacks a conventional DNA binding domain and
interacts with several other members of the nuclear
receptor superfamily to inhibit their receptor transcriptional
activity. It is interesting to note that the mutations in SHP
that have been associated with moderate obesity in
humans prevent the inhibition of ERRγ activity [Sanyal et
al., 2002].
ERR activity can be modulated by synthetic
ligands
Despite the absence of response to natural estrogens, it
has been reported that the transcriptional activity of all
ERR isoforms is inhibited by the synthetic estrogen analog
diethylstilbestrol (DES) [Coward et al., 2001;Tremblay
et al., 2001b].The constitutive transcriptional activity of
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by the selective estrogen receptor modulator (SERM)
4-hydroxytamoxifen (OHT), which behaves like a selective
inverse agonist, causing the dissociation of coactivator
protein [Coward et al., 2001;Tremblay et al., 2001a].
Recently, bisphenol A, a ubiquitous environmental
contaminant with estrogenic activity, was shown to bind
to ERRγ and antagonize the repression of ERRγ activity
induced by OHT [Takayanagi et al., 2006]. Also,
toxaphene and chlordane, two organochlorine pesticides
with estrogen-like activity, have been identified as weak
antagonists for ERRα [Yang and Chen, 1999]. However,
mutation of phenylalanine 329, an amino acid crucial for
the constitutive activity of the receptor, to an alanine
residue, allowed toxaphene to act as an ERRα agonist
instead [Chen et al., 2001]. In addition, the isoflavones
genistein, daidzein, and biochanin A and the flavone
6,3',4'-trihydroxyflavone were identified as agonists of the
ERRs by mammalian two-hybrid experiments under
comparable conditions to those for the activation of ERα
and ERβ [Suetsugi et al., 2003]. It should be noted that
binding of the organochlorine pesticide molecules to
ERRα could not be directly demonstrated [Tremblay et
al., 2001b] and that structure-based predictions showed
that flavone and isoflavone cannot be accommodated
within the ERR binding pocket [Greschik et al., 2002].
Although these compounds constitute useful tools to study
the regulation of the ERRs, they share the pitfall of being
non-specific to the ERRs, as they modulate the activity
of other nuclear receptors such as the ERs. However,
several synthetic compounds have recently been
characterized as ERR-specific ligands. XCT790 is a highly
specific inverse agonist for ERRα that disrupts the
interaction between ERRα and PGC-1α and has no effect
on either the ERs or the other ERR isoforms [Busch et
al., 2004;Willy et al., 2004], while GSK5182, a tamoxifen
analog, showed improved inverse agonist selectivity for
ERRγ [Chao et al., 2006]. On the other hand, the
structurally-related phenolic acyl hydrazones GSK4716
and DY131 were reported to effectively and selectively
activate ERRβ and ERRγ [Yu and Forman, 2005;
Zuercher et al., 2005].
The possible existence of a natural ligand for the ERRs
remains an unresolved question.The initial crystal
structure of unliganded ERRγ showed that the
ligand-binding pocket is very small, approximately 280 Å
[Greschik et al., 2002]. Likewise, the unoccupied volume
of the ligand-binding pocket of the unliganded ERRα
bound to a PGC-1α coactivator peptide was reported to
be ~100 Å [Kallen et al., 2004], suggesting that a natural
agonist would have to be composed of at most four to
five non-hydrogen atoms. However, the crystal structures
of the GSK4716 agonist-bound ERRγ and of the
cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine
inverse agonist-bound ERRα revealed that these ligands
can force the rearrangement of amino acid residues in
the respective ligand binding domains that allows access
of the ligands to a larger ligand-binding pocket.The
results of these experiments thus suggest that the
plasticity of the ERR ligand binding pockets could allow
for larger compounds to act as natural ligands [Kallen et
al., 2007;Wang et al., 2006].The crystal structures of
ERRα and ERRγ ligand-binding domains also provided
strong evidence for ligand-independent transactivation
by these receptors. In both cases, the apo-receptors are
in a permanent active configuration and thus ready to
interact with coregulatory proteins [Greschik et al., 2002;
Kallen et al., 2007; Kallen et al., 2004;Wang et al., 2006].
Because binding of the agonist GSK4617 does not affect
the orientation of the AF-2 helix, the mechanism by which
GSK4617 activates ERRγ is currently unknown. In
contrast, binding of DES and 4-OHT to ERRγ induces the
displacement of the AF-2 helix to a position that interferes
with the recruitment of coactivators [Greschik et al., 2004;
Wang et al., 2006].
ERR target genes
Identification of the binding site
The physiological roles played by nuclear receptors can
often be ascribed by investigating their target genes.
Unbiased binding site selection and characterization of
the first ERR-responsive genes defined the ERR response
element (ERRE) as the consensus nucleotide sequence
TCAAGGTCA [Johnston et al., 1997; Sladek et al., 1997a;
Vega and Kelly, 1997]. Bioinformatic analysis of a large
set of ERR target promoters identified using a
combination of chromatin immunoprecipitation (ChIP)
and genomic DNA arrays (ChIP-on-chip) confirmed that
the TCAAGGTCA motif serves as the main ERR binding
site in vivo (Figure 1B) [Dufour et al., 2007]. Although the
consensus ERRE contains a single nuclear receptor core
binding half-site, the ERRs can bind DNA either as
monomers, homodimers or heterodimers (Figure 1C)
[Barry et al., 2006; Dufour et al., 2007; Gearhart et al.,
2003; Huppunen and Aarnisalo, 2004; Johnston et al.,
1997; Sladek et al., 1997a;Vanacker et al., 1999a]. ERRα
and ERRβ have also been shown to bind the estrogen
response element (ERE) as homodimers [Vanacker et
al., 1999b;Yang et al., 1996; Zhang and Teng, 2000],
and two studies even suggested that ERα and ERRα
could heterodimerize in vitro [Johnston et al., 1997;Yang
et al., 1996]. However, convincing evidence that the ERRs
can commonly bind to EREs and/or interact in a
physiologically significant manner with the ERs in vivo is
still lacking. A study of the TFF1 (pS2) gene showed that
while the promoter contains both an ERE and an ERRE,
regulation by the ERRs is lost only when the ERRE is
ablated, suggesting that the ERRE is the ERRs’ legitimate
binding site, at least on this promoter [Lu et al., 2001].
ERR target promoters
Biochemical purification of HeLa cell nuclear extract
proteins that bind to the Simian Virus 40 (SV40) late
promoter first identified ERRα as a repressor of the
transcription of the SV40 late genes [Wiley et al., 1993;
Zuo and Mertz, 1995]. In contrast, the ERRs have been
shown to mainly activate the expression of cellular genes.
Until recently, most ERR target genes had been identified
through the discovery of a putative ERRE in the promoters
of genes of interest.These included genes encoding the
medium-chain acyl coenzyme A dehydrogenase (MCAD
or Acadm) [Sladek et al., 1997a;Vega and Kelly, 1997],
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al., 1998b], the thyroid receptor α (TRα) [Vanacker et al.,
1998a], aromatase [Yang et al., 1998], lactoferrin [Yang
et al., 1996], the orphan nuclear receptor SHP [Sanyal
et al., 2002], endothelial nitric oxide synthase (eNOS)
[Sumi and Ignarro, 2003], PPARα [Huss et al., 2004],
pyruvate dehydrogenase kinase 4 (PDK4) [Araki and
Motojima, 2006;Wende et al., 2005; Zhang et al., 2006a],
monoamine oxidase B (MAO-B) [Willy et al., 2004; Zhang
et al., 2006b], ERRα itself [Laganiere et al., 2004; Liu et
al., 2005; Mootha et al., 2004], apolipoprotein A4 (ApoA4)
[Carrier et al., 2004], phosphoenolpyruvate carboxykinase
(PEPCK) [Herzog et al., 2006], surfactant protein A (SP-A)
[Liu et al., 2006], RIP-140/Nrip1 [Nichol et al., 2006],
mitofusin 2 [Soriano et al., 2006], Polo-like kinase 2 (Plk2)
[Park et al., 2007] and uncoupling protein 1 (UCP-1)
[Debevec et al., 2007]. A second, more global approach
to identifying ERR-responsive genes was to exploit the
observation that ERRα transcriptional activity is highly
stimulated in the presence of PGC-1α.Various cell lines
were first infected with an adenovirus expressing either
wild-type PGC-1α or a PGC-1α variant engineered to
specifically interact with ERRα, and differential gene
expression profiling was then carried out using DNA
microarrays [Gaillard et al., 2006; Mootha et al., 2004;
Rangwala et al., 2007; Schreiber et al., 2004]. A small
subset of bona fide ERRα targets were further identified
using a combination of computational biology, small
inhibitory RNAs (siRNAs) against ERRα, a specific
antagonist, as well as DNA binding assays and
cotransfection of reporter genes.These targets included
several genes involved in oxidative phosphorylation
(OXPHOS) and mitochondrial biogenesis, such as ATP
synthase b (ATPsynb), cytochrome c (CYCS), COX4,
GABPA, adenine nucleotide translocator 1 (ANT1) and
carnitine palmytoyltransferase 1A (CPT1A), thus
suggesting that ERRα could serve as a conduit for
PGC-1α action in mitochondrial biogenesis and the
OXPHOS pathway.
A powerful approach to identify direct target genes of
nuclear receptors is to determine their occupancy on a
genome-wide scale by using the ChIP-on-chip technology
[Carroll et al., 2005; Carroll et al., 2006; Laganiere et al.,
2005; Odom et al., 2004].This technique was recently
used to appraise the role of ERRα and ERRγ in the adult
heart [Dufour et al., 2007], of ERRγ in the newborn heart
[Alaynick et al., 2007] and of ERRα in bone
marrow-derived macrophages [Sonoda et al., 2007].
Together, these studies identified more than 500
promoters that considerably expanded the repertoire of
direct ERR target genes encoding cytosolic and
mitochondrial proteins involved in the control of energy
metabolism. In addition, these studies showed that the
ERRs control tissue-specific functions, such as fuel
sensing and contractile work in the heart and bacterial
clearance in macrophages. Further analyses of the
ChIP-on-chip data demonstrated that ERRα and ERRγ
target the same promoter as non-obligatory heterodimers
and cooperate with other transcription factors, namely
CREB and STAT3, to control of the expression of
metabolic genes [Dufour et al., 2007].
Regulatory networks
Review of the data gathered on ERR coregulatory
proteins and target genes described above also reveals
an important emerging concept of ERRs functioning in a
regulatory network. First, induction of PGC-1α expression
by physiological stimuli leads to the upregulation of ERRα,
which in turn stimulates its own expression, thereby
generating a positive feedback loop [Laganiere et al.,
2004; Mootha et al., 2004]. Second, ERRα can also
stimulate the expression of the corepressor RIP140 and
SHP, thereby providing an inhibitory feedback mechanism
to control the expression of its target genes [Nichol et al.,
2006; Sanyal et al., 2002].Third, since the three ERR
isoforms can regulate the same target genes as homo-
or heterodimers, the expression of these genes can be
differentially regulated depending on the levels of
individual ERR isoform in each tissue.The existence of
such networks has been shown in vivo where, in the
ERRα null heart, the expression of RIP140 is
downregulated, while that of PGC-1α is upregulated at a
time when the expression of ERRγ is also elevated
[Dufour et al., 2007].The compensatory mechanism was
particularly evident in HL-1 cardiomyocytes, where ERRγ
was shown to play an important role in maintaining the
expression of ERRα target genes. A similar compensatory
mechanism was observed in the neonatal heart lacking
ERRγ [Alaynick et al., 2007].
Phenotypic analyses of ERR null mice
ERRα null mice: metabolic defects have
tissue-specific consequences
Initial phenotypic analysis of the ERRα null mice showed
them to be viable and fertile with no gross anatomical
alterations, with the exception of reduced body weight
and peripheral fat deposits [Luo et al., 2003].The ERRα
null mice also showed altered expression of genes
involved in lipid metabolism and OXPHOS in several
tissues, including white adipose tissue, muscle and small
intestine [Carrier et al., 2004; Huss et al., 2004; Luo et
al., 2003]. Although the changes observed in the
expression of metabolic genes in these tissues should,
in theory, lead the mice to burn less fat and spend less
energy, the mice are paradoxically lean and resistant to
high fat diet-induced obesity [Luo et al., 2003]. However,
it was observed that, in the white adipose tissue of ERRα
null mice, genes involved in fat catabolism were
upregulated, while genes involved in triglyceride synthesis
were downregulated.These data suggest that the ERRs
can potentially function as both repressor and activator
of gene expression in a tissue- and gene-specific manner.
Together, these observations imply a more complex and
tissue-specific role for ERRα in the control of energy
metabolism in the whole animal. Indeed, subsequent
investigation of the ERRα null mice showed that
enterocytes from the null mice displayed a lower capacity
for β-oxidation, and that ERRα-deficient pups exhibited
a significant lipid malabsorption and fat transport [Carrier
et al., 2004]. In addition, ERRα null mice display a
reduced mitochondrial mass in brown adipose tissue and
impaired thermogenic capacity in response to cold
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to a normal body temperature [Villena et al., 2007]. ERRα
is thus essential for the organism in situations of high
energy demand and defects in ERRα function could
contribute to pathological states caused by mitochondrial
dysfunction.
Given the observation that ERRα orchestrates a
comprehensive transcriptional program in the heart
[Dufour et al., 2007] and the known link between
metabolic disturbance and pathologic cardiac hypertrophy,
ERRα null mice were recently tested for their response
to stressors known to cause heart failure. Hearts of ERRα
null mice subjected to pressure overload displayed
chamber dilatation, reduced left ventricular shortening,
depletion of the phosphocreatine pool and reduced ATP
synthesis [Huss et al., 2007], indicating that ERRα is
essential for the bioenergetic and functional adaptation
to cardiac hemodynamic stressors.
Finally, recent studies of ERRα null macrophages showed
that ERRα is required for the induction of mitochondrial
reactive oxygen species (ROS) production and efficient
clearance of pathogens in response to IFN-γ [Sonoda et
al., 2007]. Consequently, the mitochondrial metabolic
defect renders the ERRα null mice susceptible to infection
by Listeria monocytogenes.The activation of ERRα by
IFN-γ was also found to be dependent on the presence
of the coactivator PGC-1β.
ERRβ: control of cell fate
Expression of ERRβ during early embryogenesis defines
a subset of extra-embryonic ectoderm predestined to
form the dome of the chorion [Luo et al., 1997; Pettersson
et al., 1996]. Phenotypic analysis of the ERRβ null mice
indeed showed abnormal chorion development associated
with an overabundance of trophoblast giant cells and a
severe deficiency of diploid trophoblasts [Luo et al., 1997].
Consequently, the ERRβ null mice die in utero at 10.5
days post-coitum due to impaired placental formation.
Strikingly, treatment of trophoblast stem cells with DES,
a synthetic estrogen that promotes coactivator release
from ERRβ and inhibits its transcriptional activity, led to
their differentiation toward the polyploid giant cell lineage
[Tremblay et al., 2001b]. In addition, DES-treated
pregnant mice exhibited abnormal early placenta
development associated with an overabundance of
trophoblast giant cells and an absence of diploid
trophoblast.These studies thus provided evidence for
steroid-like control of trophoblast development.
Although essential for placental formation, tetraploid
rescue experiments, as well as tissue-specific ablation
of Esrrb, demonstrated that the ERRβ null embryos can
develop normally and generate fertile adult animals of
both sexes [Chen and Nathans, 2007; Luo et al., 1997;
Mitsunaga et al., 2004]. However, the ERRβ null mice of
both sexes were found to have a reduced number of
primordial germ cells in their gonads [Mitsunaga et al.,
2004]. In addition, ERRβ null mice display abnormal
development of the endolymph-producing cells of the
inner ear, suggesting that potential ERRβ ligands could
be used to treat some disorders of hearing and balance
[Chen and Nathans, 2007].Taken together, these
phenotypes advocate a more precise role for ERRβ than
the other two ERR isoforms in the control of the fate of
specific cell types during development.
ERRγ is required for the transition to oxidative
metabolism in the postnatal heart
ERRγ is expressed at high levels in the fetal and postnatal
heart. ERRγ null mice display a reduction in ventricular
mass and die shortly after birth [Alaynick et al., 2007].
Loss of ERRγ blocks the transition from a predominant
dependence on carbohydrates as substrates during the
fetal period to greater dependence on oxidative
metabolism in postnatal life.The impairment in this switch
resulted in lactatemia, electrocardiogram abnormalities,
high mitochondrial genome number and altered electron
transport chain biochemical activities [Alaynick et al.,
2007]. Since pathologic conditions such as heart failure
and cardiac hypertrophy can re-induce carbohydrate
utilization, these findings suggest that like ERRα, ERRγ
could be targeted for the management and/or treatment
of cardiomyopathies.
Table 1.  List of known ERR functions and associated target genes.
The table shows a list of physiological and developmental functions
regulated by the three ERR isoforms in diverse tissues. Prototypic ERR
target genes for each tissue are also listed. References to ERR functions
and target genes can be found in the main text.
ERRs and human diseases
Cancer
Evidence is accumulating towards a potential implication
of the ERRs in the etiology of various types of cancer.
The expression of all three ERR isoforms has been
monitored in cancer cell lines or primary tumors derived
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al., 2004; Zhou et al., 2006], ovary [Sun et al., 2005],
prostate [Cheung et al., 2005; Fujimura et al., 2007],
endometrium [Gao et al., 2006; Sun et al., 2006;
Watanabe et al., 2006] and colon [Cavallini et al., 2005].
In particular, ERRα has been identified as a bad
prognosis indicator owing to its correlation with
unfavorable biomarkers such as ERα negativity and
elevated ErbB2 expression. On the other hand, ERRγ
was associated with more favorable biomarkers such as
hormone responsiveness in estrogen/progesterone
receptor-positive tumors and expression of ErbB4, and
its presence is therefore considered as a better prognosis
indicator. Increased ERRα levels have also been
associated with a higher risk of recurrence and poor
clinical outcome in human breast carcinoma [Ariazi et al.,
2002; Suzuki et al., 2004]. At the molecular level, it has
been demonstrated that ERRα is phosphorylated in
response to EGF signaling in MCF-7 breast cancer cells,
a posttranslational modification that was linked to
selective gene activation by ERRα [Barry and Giguere,
2005]. Likewise, ERRα phosphorylation status and
transcriptional activity were shown to be higher in a breast
cancer cell line expressing high levels of ErbB2, while
inhibition of ErbB2 signaling abrogated ERRα-induced
transcription in these cells [Ariazi et al., 2007]. Lastly,
coordinated upregulation of ERRα and its coactivators,
PGC-1α and PGC-1β, as well as genes involved in
glycolysis, tricarboxylic acid cycle and the OXPHOS
pathway was observed in a human breast cancer model
for brain metastasis [Chen et al., 2007].These findings
suggest that ERRα may direct a transcriptional switch
that supports expression of oxidative metabolic pathways
in metastatic cancer cells in the brain.
Osteoporosis, bone maintenance and cartilage
formation
Given the structural and functional similarities between
the ERRs and ERs, and the important role that estrogens
play in bone formation and maintenance, a potential role
for ERRα in bone physiology is under investigation
[Bonnelye and Aubin, 2005; Giguere, 2002]. ERRα is
expressed in bone cells [Bonnelye and Aubin, 2002;
Bonnelye et al., 2002; Bonnelye et al., 2001; Bonnelye
et al., 1997; Sladek et al., 1997a] and directly regulates
osteoblast-associated genes such as OPN [Vanacker et
al., 1998b], lactoferrin [Yang et al., 1996], TRα [Vanacker
et al., 1998a], aromatase [Yang et al., 1998] and eNOS
[Sumi and Ignarro, 2003]. In addition, ERRα expression
has been shown to be regulated by estradiol, both in
cultured rat calvaria cells and in vivo [Bonnelye et al.,
2002]. However, it is currently unknown whether ERRα
regulates estrogen-sensitive genes or interferes with
estrogen signaling through indirect mechanisms. A
statistically significant association between bone mass
density (BMD) of white premenopausal women and
ESRRA23 was also observed in a genetic association
study [Laflamme et al., 2005].Women with more copies
of ESRRA23 showed a higher BMD.The study concluded
that lower copy number of ESRRA23 is associated with
lower BMD and likely increased risk of bone fracture.
Figure 2.  Central role played by ERRα and ERRγ in the control of
energy metabolism. Induction of the expression of the coactivator
PGC-1α upon diverse physiological stimuli leads to an augmentation in
ERR transcriptional activity, as well as an increase in ERRα levels through
an autoregulatory mechanism.The ERRs then upregulate the expression
of other transcription factors, such as PPARα and GABPA, thus amplifying
the original signal.These factors, working in concert with PGC1α and
PGC-β, stimulate the expression of a vast genetic program controlling
mitochondrial biogenesis, OXPHOS and ROS production. ERRα also
stimulates the expression of RIP140, which provides an inhibitory feedback
mechanism. Mitochondrial output is then used in a tissue-specific manner
to modulate diverse biological responses.
Expression of ERRα has also been reported in fetal and
adult rat chondrocytes in growth plate and articular
cartilage and in the rat chondrogenic cell line C5.18
[Bonnelye et al., 2007]. Overexpression of ERRα in C5.18
cells induces the expression of the transcription factor
SOX9, an important gene in cartilage formation. On the
other hand, reduction of ERRα expression by a siRNA
led to inhibition of cartilage formation and maturation of
proliferating chondrocytes into hypertrophic chondrocytes
in vitro.
Obesity
As noted above, ERRα is expressed in tissues with a
high capacity for β-oxidation, is a main conduit for
PGC-1α and PGC-1β activity, and the ERRα null mice
have reduced body weight and are resistant to high fat
diet-induced obesity. In addition, ESRRA is located on
chromosome 11q13 [Shi et al., 1997; Sladek et al.,
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(BMI) and fat content [Perusse et al., 2005]. Association
studies between ESRRA variants located either in the
promoter (ESRRA23, [Laganiere et al., 2004]) or in the
coding region (Pro116Pro, [Larsen et al., 2007]) with
obesity and type 2 diabetes have so far given mixed
results.While Kamei et al. [Kamei et al., 2005] found that
the 2.3 genotype of ESRRA23 was associated with a
higher BMI in Japanese individuals, Larsen et al. [Larsen
et al., 2007] found no association of the ESRRA23 or
Pro116Pro variants with obesity or type 2 diabetes in
Danish whites.
Closing remarks
While the ERRs remain orphan nuclear receptors as the
search for a natural ligand continues, it has become clear
that the three ERR isoforms are essential transcriptional
regulators of development and physiology (Table 1).
Control of energy metabolism, through their interaction
with members of the PGC-1 family of coactivator proteins,
as well as with the corepressor RIP140, appears to be at
the core of ERR biological activities (Figure 2). Given that
the ERRs are proven druggable targets, it is hoped that
the development of isoform-specific ERR agonists and
antagonists will lead to new therapeutic approaches to
manage and/or treat a variety of diseases that could
include cardiomyopathies, osteoporosis, infection by
pathogens, diabetes, obesity and cancer.
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